REG - IXICO plc - Director/PDMR Shareholdings
28/10/2024 11:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241028:nRSb8839Ja&default-theme=true
RNS Number : 8839J IXICO plc 28 October 2024
28 October 2024
IXICO PLC
("IXICO" or the "Company")
Director/PDMR Share Dealings
Further to the announcements made on 8 October 2024 and 25 October 2024, and
pursuant to the recent fundraising, the Company confirms that the following
directors of the Company have subscribed for New Ordinary Shares at the Issue
Price of 9.5 pence per Ordinary Share as follows:
Director/PDMR Name No. of New Ordinary Shares Subscribed Resultant Shareholding post transaction % of voting rights post transaction
Bram Goorden 526,315 526,315 0.6%
Grant Nash 105,263 505,263 0.5%
Dipti Amin 105,263 105,263 0.1%
Katherine Rogers 52,631 52,631 0.1%
For further information please contact:
IXICO plc +44 (0) 20 3763 7499
Bram Goorden, Chief Executive Officer
Grant Nash, Chief Financial Officer
Cavendish Capital Markets Limited +44 (0) 20 7220 0500
(Nominated adviser and sole broker)
Giles Balleny / Dan Hodkinson (Corporate Finance)
Nigel Birks (Life Sciences Specialist Sales)
Harriet Ward (Corporate Broking)
Michael F Johnson / Tamar Cranford Smith (Sales)
About IXICO
IXICO is dedicated to delivering insights in neuroscience to help transform
the advancement of investigational therapies for neurological diseases, such
as Huntington's disease, Parkinson's disease and Alzheimer's disease. The
Company's purpose is to advance medicine and human health by turning data into
clinically meaningful information, providing valuable new insights in
neuroscience by supporting pharmaceutical companies across all phases of CNS
clinical research. IXICO's goal is to be a leading advocate of artificial
intelligence in medical image analysis.
IXICO has developed and deployed breakthrough data analytics, at scale,
through its remote access technology platform, to improve the return on
investment in drug development and reduce risk and uncertainty in clinical
trials for the Company's pharmaceutical clients.
More information is available on www.IXICO.com (http://www.ixico.com/) and
follow us on X (formerly Twitter) @IXICOnews
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Bram Goorden
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name IXICO plc
b) LEI 2138005M1F59O6HWSA97
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares in IXICO plc
Identification code ISIN: GB00BFXR4C20
b) Nature of the transaction Subscription for Ordinary shares
c) Price(s) and volume(s)
Price(s) Volume(s)
9.5 pence 526,315
d) Aggregated information
N/A - single transaction
- Aggregated volume
- Price
e) Date of the transaction 28 October 2024
f) Place of the transaction Off Market Transaction
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Grant Nash
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification /Amendment Initial
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name IXICO plc
b) LEI 2138005M1F59O6HWSA97
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares in IXICO plc
Identification code ISIN: GB00BFXR4C20
b) Nature of the transaction Subscription for Ordinary shares
c) Price(s) and volume(s)
Price(s) Volume(s)
9.5 pence 105,263
d) Aggregated information
N/A - single transaction
- Aggregated volume
- Price
e) Date of the transaction 28 October 2024
f) Place of the transaction Off Market Transaction
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Dipti Amin
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification /Amendment Initial
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name IXICO plc
b) LEI 2138005M1F59O6HWSA97
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares in IXICO plc
Identification code ISIN: GB00BFXR4C20
b) Nature of the transaction Subscription for Ordinary shares
c) Price(s) and volume(s)
Price(s) Volume(s)
9.5 pence 105,263
d) Aggregated information
N/A - single transaction
- Aggregated volume
- Price
e) Date of the transaction 28 October 2024
f) Place of the transaction Off Market Transaction
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Katherine Rogers
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification /Amendment Initial
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name IXICO plc
b) LEI 2138005M1F59O6HWSA97
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares in IXICO plc
Identification code ISIN: GB00BFXR4C20
b) Nature of the transaction Subscription for Ordinary shares
c) Price(s) and volume(s)
Price(s) Volume(s)
9.5 pence 52,631
d) Aggregated information
N/A - single transaction
- Aggregated volume
- Price
e) Date of the transaction 28 October 2024
f) Place of the transaction Off Market Transaction
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBGBDGXUDDGSIRecent news on IXICO
See all newsREG - IXICO plc - Trading Update
AnnouncementREG - IXICO plc - Contract Win
AnnouncementREG - IXICO plc - Further Validation of IXICO’s AI Imaging Platform
AnnouncementREG - IXICO plc - Issue of share options and PDMR dealing
AnnouncementREG - IXICO plc - Result of AGM
Announcement